Flowonix Medical Revenue and Competitors

Mount Olive, NJ USA

Location

$52M

Total Funding

Estimated Revenue & Valuation

  • Flowonix Medical's estimated annual revenue is currently $4.4M per year.(i)
  • Flowonix Medical received $15.5M in venture funding in June 2016.
  • Flowonix Medical's estimated revenue per employee is $125,500
  • Flowonix Medical's total funding is $52M.

Employee Data

  • Flowonix Medical has 35 Employees.(i)
  • Flowonix Medical grew their employee count by -36% last year.

Flowonix Medical's People

NameTitleEmail/Phone
1
Director Clinical EngineeringReveal Email/Phone
2
Senior Director, Regulatory AffairsReveal Email/Phone
3
Document Control & Regulatory Operations ManagerReveal Email/Phone
4
Territory ManagerReveal Email/Phone
5
Product Analysis Team LeadReveal Email/Phone
6
Senior Quality TechnicianReveal Email/Phone
7
Assistant ControllerReveal Email/Phone
8
Product Surveillance AssociateReveal Email/Phone
9
Business AdministratorReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$7.8M3111%N/AN/A
#2
$12.3M49-4%N/AN/A
#3
$15.1M607%N/AN/A
#4
$8.8M35-8%N/AN/A
#5
$3M129%N/AN/A
#6
$300.4M11973%N/AN/A
#7
$311.7M12422%N/AN/A
#8
$0.3M1-96%N/AN/A
#9
$8.3M333%N/AN/A
#10
$13.6M548%N/AN/A
Add Company

What Is Flowonix Medical?

Flowonix is a medical device company dedicated to helping those who suffer from chronic disorders. Our team has decades of experience developing unique and reliable medical devices to improve lifestyles. Using one of a kind technology, Flowonix has developed an implantable drug pump designed to deliver therapeutic drugs into the spine to relieve a variety of chronic disorders and help patients return to normal lives. Currently, Flowonix is focused on alleviating chronic pain. We are dedicated to working with healthcare professionals to help ease suffering and allow people to reclaim their lives through innovation and therapy advancements. Flowonix's engineering team has a long history of developing pump technology. Beginning in the early 1970's, the team has been responsible for many of the early innovations, including: First implant for anticoagulant Heparin First human implant for Floxuridine (FUDR, an anti-cancer chemotherapy drug) First human implant for insulin First human implant for morphine First valve regulated intrathecal pump US Patents on: Programmable valve pumps Implantable, refillable pumps Long life power supplies for implantable pumps Septumless implantable pumps Low power electromagnetic valves Pump diagnostic systems ...and many more. 12 issued US patents, with 7 more patents pending.

keywords:Biotechnology,Healthcare,Medical Devices,Pharmaceuticals

$52M

Total Funding

35

Number of Employees

$4.4M

Revenue (est)

-36%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Flowonix Medical News

2022-04-20 - Analgesic Infusion Pumps Market Size, Outlook And Forecast ...

... B. Braun, BD, Medtronic, Smiths Medical, Johnson & Johnson, Flowonix Medical, Fresenius, Micrel Medical Devices, Mindray.

2022-04-20 - FDA Approves Programmable Pump System

The FDA has given marketing approval to the Prometra II 40-mL programmable pump and its associated programmer software (Flowonix Medical Inc).

2022-04-17 - Intrathecal Pumps Market Segments and Forecast from 2022 ...

Flowonix Medical, Inc. Zimmer Biomet Medtronic. Intrathecal pumps are a type of analgesic infusion pump that delivers medication directly into a...

2016-06-02 - Medical Device Company Flowonix Medical Raises $15.5M in Financing

Flowonix Medical, Inc., a Mount Olive, N.J.-based medical device company focused on providing advanced, implantable drug delivery solutions, raised $15.5m in financing. The transaction included: – $10.5m investment led by insiders including Clarus Ventures and other existing investors; – $5.0 ...

2015-06-05 - Proven Process client Flowonix Medical Inc. achieves FDA PMA Approval of Prometra II infusion device

MANSFIELD, MA – Proven Process Medical Devices, Inc., a global leader in the design, development, validation, and manufacture of Class II and Class III medical devices, announced today that its client Flowonix Medical Inc. has secured PMA-Supplemental approval from the FDA for its next-generatio ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$8.8M36-5%N/A
#2
$7.3M5622%N/A
#3
$17.7M605%N/A
#4
$15.8M9029%N/A
#5
$122.3M4662%N/A

Flowonix Medical Funding

DateAmountRoundLead InvestorsReference
2014-11-13$40.0MUndisclosedÉlevage Capital ManagementArticle
2016-06-02$15.5MUndisclosedClarus VenturesArticle